Nuclear Medicine and Biology
Volume 35, Issue 2 , Pages 233-237 , February 2008

Bioevaluation of 32P patch designed for the treatment of skin diseases

  • Maria Jimena Salgueiro

      Affiliations

    • Radioisotope Laboratory, School of Pharmacy and Biochemistry, University of Buenos Aires, 1113 Buenos Aires, Argentina
    • Corresponding Author InformationCorresponding author. Radioisotope Laboratory, Physics Department, School of Pharmacy and Biochemistry, University of Buenos Aires, 1113 Buenos Aires, Argentina. Tel.: +5411 4964 8202x33; fax: +5411 4964 8202x31.
    • ,
  • Hebe Duran

      Affiliations

    • Radiobiology Department, National Energy Atomic Commission, 1150 Buenos Aires, Argentina
    • ,
  • Monica Palmieri

      Affiliations

    • Biodiversity and Experimental Biology Department, School of Exact and Natural Sciences, University of Buenos Aires, 1113 Buenos Aires, Argentina
    • ,
  • Rosana Pirchio

      Affiliations

    • Dosimetry Department, National Energy Atomic Commission, 1150 Buenos Aires, Argentina
    • ,
  • Vanina Medina

      Affiliations

    • Radioisotope Laboratory, School of Pharmacy and Biochemistry, University of Buenos Aires, 1113 Buenos Aires, Argentina
    • ,
  • Ricardo Ughetti

      Affiliations

    • Research and Development Department, Laboratorios Bacon SAIC, 1603 Buenos Aires, Argentina
    • ,
  • Maximo Croci

      Affiliations

    • Institute of Immunooncology, Dr. E. Crescenti, 1187 Buenos Aires, Argentina
    • ,
  • Jorge Nicolini

      Affiliations

    • Research and Development Department, Laboratorios Bacon SAIC, 1603 Buenos Aires, Argentina
    • ,
  • Marcela Zubillaga

      Affiliations

    • Radioisotope Laboratory, School of Pharmacy and Biochemistry, University of Buenos Aires, 1113 Buenos Aires, Argentina

Received 21 June 2007 ,Revised 6 August 2007 ,Accepted 16 August 2007.

References 

  1. Behrens CF, King ER, Carpenter JWJ. Medicina nuclear. 1st ed. Barcelona, España: Editorial Salvat, 1972. p. 668–95, 762–78 [North American].
  2. Veall N, Vetter H. Técnicas con radioisotopos para la investigación y el diagnóstico en clínica. In: Protein metabolism and nutrition. Buenos Aires, Argentina: Editorial EUDEBA; 1964;p. 405–411
  3. Lee JD, Park KK, Lee M, Kim E, Rhim KJ, Lee JT, et al. Radionuclide therapy of skin cancers and Bowen's disease using a specially designed skin patch. J Nucl Med. 1997;38:697–702
  4. Chung YL, Lee JD, Bang D, Lee JB, Park KB, Lee M. Treatment of Bowen's disease with a specially designed radioactive skin patch. Eur J Nucl Med. 2000;27:842–846
  5. Mukherjee A, Pandey U, Sarma HD, Pillai MRA, Venkatesh M. Preparation and evaluation of 90Y skin patches for therapy of superficial tumors in mice. Nucl Med Commun. 2002;23:243–247
  6. Mukherjee A, Pandey U, Sarma HD, Gupta SK, Ingle AD, Pillai MRA, et al. Bioevaluation of radioactive bandages in a murine model of melanoma. Int J Radiat Biol. 2003;79:839–846
  7. Chung YL, Bang D, Lee JD, Sung YO, Park KB, Lee M. Treatment of multifocal Bowen's disease with a specially designed radioactive skin patch. Br J Dermatol. 1998;139:938–939
  8. Salgueiro MJ, Durán H, Palmieri M, Pirchio R, Nicolini J, Ughetti R, et al. Design and bioevaluation of a 32P patch for brachytherapy of skin diseases. Applied Radiation and Isotopes [in press].
  9. United States Pharmacopeia-The National Formulary (USP-NF XXIX) Official monographs, NF 24, 2006, Rockville (versión español). Monograph phosphoric-32P acid pp. 1113.
  10. Anghileri LJ. In: Second International Conference of Peaceful Uses of Atomic Energy, Génova, Italia. 1958;[15 p 1575]
  11. Anghileri LJ. 32P en ratones. Influencia del tamaño de las partículas. Informe no. 158. Buenos Aires, Argentina: Comisión Nacional de Energía Atómica; 1967;
  12. Anghileri LJ, Marques R. New colloidal chromic radiophosphate (32P) for local irradiation of the central nervous system. Int J Appl Radiat Isot. 1967;18:97–100
  13. United States Pharmacopeia-The National Formulary (USP-NF XXIX) Official monographs, NF 24, 2006, Rockville (versión español). Monograph phosphoric-32P suspension pp. 1112.
  14. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmac Ther. 1992;54:63–128
  15. DuBowski A, Johnston DA, Rupp T, Beltran L, Conti CJ, DiGiovanni J. Papillomas at high risk for malignant progression arising both early and late during two-stage carcinogenesis in SENCAR mice. Carcinogenesis. 1998;19:1141–1147
  16. Aldaz CM, Conti CJ, Chen A, Bianchi A, Walter B, DiGiovanni J. Promoter independence as a feature of most skin papillomas in SENCAR mice. Cancer Res. 1991;51:1045–1050
  17. X-5 Monte Carlo Team . MCNP — a general Monte Carlo N-particle transport code, Versión 5. Los Alamos (NM): Los Alamos National Laboratory; 2003;
  18. Steel G. Basic clinical radiobiology. 2nd ed.. New York (USA): Oxford University Press; 1997;
  19. Kal HB, Veen RE. Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Strahlenther Onkol. 2005;181:717–723
  20. Evans RD. The atomic nucleus. New York (USA): Ed McGraw-Hill Book Co.; 1955;
  21. Sokal RR, Rohlf FJ. Biometry. San Francisco, CA: Freeman and Co; 1981;
  22. Rudolph R, Zelac D. Squamous cell carcinoma of the skin. Plast Reconstr Surg. 2004;114:82e–94e
  23. Locke J, Karimpour S, Young G, Lockett MA, Perez CA. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys. 2001;51:748–755

PII: S0969-8051(07)00221-1

doi: 10.1016/j.nucmedbio.2007.08.004

Nuclear Medicine and Biology
Volume 35, Issue 2 , Pages 233-237 , February 2008

Article Tools

* Image Usage & Resolution